Bayer Unsure of Support of Shareholders

  • Author: ChemistryViews.org
  • Published: 25 April 2019
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Associated Suppliers: Monsanto, St. Louis, USA | Bayer AG, Leverkusen, Germany
thumbnail image: Bayer Unsure of Support of Shareholders

Bayer will have its annual general meeting (AGM) on Friday, April 26. Voting on the ratification of the actions of the Executive Board is one major focus of German AGMs. According to Reuters, sources say that BlackRock, Bayer’s largest shareholder owning 7.2 % of the voting rights, will either abstain from or vote against ratifying the management board’s actions. Bayer’s next two biggest shareholders, Singapore state investor Temasek and Norway’s oil fund, did not comment on their voting intentions, as did the asset managers DWS and Union Investment. Asset manager Deka probably will vote against ratifying the management’s action.

The vote has no bearing on management’s liability but is regarded as an important indicator of the mood of the shareholders. Bayer's management, led by CEO Werner Baumann, received 97 % approval at last year's AGM, which took place shortly before the Monsanto takeover was completed for USD 63 billion. 

Bayer has taken over high risks with the Monsanto acquisition. In August, a US jury found Bayer liable because Monsanto had failed to warn of alleged cancer risks associated with glyphosate, the active ingredient in their weedkiller Roundup. Bayer suffered a similar defeat in a US courtroom last month, where many plaintiffs are claiming damages. The market value of Bayer decreased by around EUR 30 billion (USD 34 billion) since August 2019, according to Reuters.

The U.S. Environmental Protection Agency (EPA), the European Chemicals Agency (ECHA), and other regulators have found that glyphosate is not likely carcinogenic to humans. The World Health Organization (WHO), in contrast, classifies it as probably carcinogenic to humans.


 

Article Views: 959

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH